ShareValue scores for VVOS: Valuation 47, Quality 30, Growth 67, Health 36.

VVOS
NASDAQ

Vivos Therapeutics Inc

$0.32(-5.46%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 18%
Valuation
47
Fair Value
Price vs Value
Quality
30
Weak
Business Strength
Growth
67
Moderate
Revenue & Earnings
Health
36
Stressed
Financial Stability
Momentum
13
Bearish
Price Trend

Company Details

About

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026